Patent · US Active

Heterocyclic kinase inhibitors

US7456169B2 · kind B2 · utility

4Cited by
5References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 23, 2006
Grant dateNov 25, 2008
Priority date—
Expiry dateFeb 13, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D491/10
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds having the formulaare useful for inhibiting protein kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.